Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
City of Hope Medical Center
Eli Lilly and Company
University of Arizona
Jonsson Comprehensive Cancer Center
British Columbia Cancer Agency
Hoffmann-La Roche
Eli Lilly and Company
Eli Lilly and Company
Mayo Clinic
Turning Point Therapeutics, Inc.
Boston Pharmaceuticals
Shouyao Holdings (Beijing) Co. LTD
SWOG Cancer Research Network
University of Southern California
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)